Why Definitive Healthcare Corp.’s (DH) Stock Is Up 5.34%
As of Monday, October 05, Definitive Healthcare Corp.’s DH share price has surged by 5.34%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Stock Evaluator: Definitive Healthcare Corp. (DH)
Definitive Healthcare Corp. DH
$1.00
0.00
0.39%
October 16, 2026 4:00:00 PM
EST
Volume: 187,834
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Technology |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company’s platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, marketing and advertising agencies.Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
Commentary & Analysis
Why Definitive Healthcare Corp.’s (DH) Stock Is Down 5.35%
As of Thursday, September 17, Definitive Healthcare Corp.’s DH share price has dipped by 5.35%, which has investors questioning if this is right time to buy.Michael Rose
Why Definitive Healthcare Corp.’s (DH) Stock Is Up 15.26%
As of Wednesday, September 02, Definitive Healthcare Corp.’s DH share price has surged by 15.26%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Definitive Healthcare Corp.’s (DH) Stock Is Up 15.82%
As of Wednesday, September 02, Definitive Healthcare Corp.’s DH share price has surged by 15.82%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Definitive Healthcare Corp.’s (DH) Stock Is Down 7.15%
As of Tuesday, September 01, Definitive Healthcare Corp.’s DH share price has dipped by 7.15%, which has investors questioning if this is right time to buy.Michael Rose
Financial Summary
| Share Statistics | DH | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $106.7 | $160.3 | 23% |
|
| Shares Out (Mil) | 105.8 | 42.5 | 63% |
|
| Institutional Ownership | 83.0% | 78.5% | 51% |
|
| Float (Mil) | 38.7 | 38.7 | 41% |
|
| Beta | 1.34 | 1.17 | 77% |
|
| Avg Daily Volume (000s) | 218 | 218 | 46% |
|
| Price Change (52-week) |
(66.6%) | 45.5% | 13% |
|
| Growth | DH | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 15.3% | 11.8% | 74% |
|
| Net Income (5yr) | (21.4%) | 2.7% | 19% |
|
| EPS (5yr) | na | 15.5% | na |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 33.4% | (15.8%) | 88% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 7 | 7 | 7 | |
| Current EPS | $0.042 | $0.195 | $0.187 | |
| Month Ago EPS | $0.042 | $0.195 | $0.187 | |
| # Rev Up | 2 | 0 | 2 | |
| # Rev Down | 0 | 4 | 0 | |
| Three Months Ago EPS | $0.043 | $0.184 | $0.181 | |
| Year/Year Chg | (182.4%) | (115.0%) | (114.2%) | |
| Financials | DH | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $233 | $202 | 33% |
|
| Net Income (TTM) (Mil) | ($168) | ($9) | 8% |
|
| EPS (TTM) | ($1.611) | ($1.000) | 17% |
|
| Operating Cash Flow (TTM) (Mil) | $41 | ($1) | 45% |
|
| Net Cash Flow (TTM) (Mil) | $90 | $3 | 76% |
|
| Long-Term Debt (Q1) (Mil) | $156 | $18 | 48% |
|
| Enterprise Value (Q1) (Mil) | $112 | $160 | 22% |
|
| Valuation | DH | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.74 | 1.30 | 16% |
|
| P/E | na | 42.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 2.8 | na |
|
| Ratios | DH | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 83.8% | 60.9% | 91% |
|
| Net Margin | (72.3%) | (26.3%) | 9% |
|
| ROA | (26.6%) | (22.8%) | 18% |
|
| ROE | (75.0%) | (9.8%) | 12% |
|
| Liabilities to Assets | 62.2% | 33.3% | 57% |
|
| F-Score | 7 | 4 | 82% |
|
Passing Stock Screens
As of 10/16/2026, from a list of 60 stock screening strategies,
FACTOR STRATEGY
Dual Cash Flow Screen
Factors: Quality, Growth
An analysis that can provide advance notice that a company may be facing financial trouble, though earnings and sales appear strong.
| Performance Since Inception: | 11.2% |
| +/- S&P 500: | +3.7 |
